Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
AZITHROMYCIN FOR THE CURE OF HELICOBACTER-PYLORI INFECTION
Autore:
DIMARIO F; DALBO N; GRASSI SA; RUGGE M; CASSARO M; DONISI PM; VIANELLO F; KUSSTATSCHER S; SALANDIN S; GRASSO GA; FERRANA M; BATTAGLIA G;
Indirizzi:
UNIV PADUA,CATTEDRA MALATTIE APPARATO DIGERENTE,IST MED INTERNA,VIA GIUSTINIANI 2 I-35128 PADUA ITALY REPARTO MED INTERNA MAROSTICA VI ITALY GASTROENTEROL SERV OC VENEZIA ITALY UNIV PADUA,CATTEDRA ISTOCHIM & IMMUNOISTOCHIM PATOL PADUA ITALY
Titolo Testata:
The American journal of gastroenterology
fascicolo: 2, volume: 91, anno: 1996,
pagine: 264 - 267
SICI:
0002-9270(1996)91:2<264:AFTCOH>2.0.ZU;2-1
Fonte:
ISI
Lingua:
ENG
Soggetto:
DUODENAL-ULCER; CAMPYLOBACTER-PYLORI; MACROLIDE; INVIVO; TISSUE; TRIAL;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
25
Recensione:
Indirizzi per estratti:
Citazione:
F. Dimario et al., "AZITHROMYCIN FOR THE CURE OF HELICOBACTER-PYLORI INFECTION", The American journal of gastroenterology, 91(2), 1996, pp. 264-267

Abstract

Objectives: Azithromycin, a new antibiotic chemically related to erythromycin, has been proposed for the cure of Helicobacter pylori, achieving high gastric tissue levels (above the MIC for H. pylori) after oral administration. The aim of the study was to establish whether azithromycin plus metronidazole in association with either omeprazole or bismuth subcitrate is useful in curing H. pylori infection of the stomach. Patients and Methods: The study involved 132 dispeptic patients whoproved to be H. pylori infected by antral and corpus histology (Giemsa, modified) and rapid urease test (CLO test); the Sydney system was used to classify the gastritis. Sixty-three patients received bismuth subcitrate 120 mg q.i.d. for 14 days plus azithromycin 500 mg o.d. for the first 3 days plus metronidazole 250 mg q.i.d. for the first 7 days; 69 patients received omeprazole 40 mg for 14 days plus azithromycin 500 mg o.d. for the first 3 days plus metronidazole 250 mg q.i.d. for the first 7 days. Patients were well matched for common clinical variables. Cure of H. pylori infection was assessed by the same methods 2 months after completion of treatment. Results: Eleven patients dropped out of the study, only one reporting side effects (nausea, vomiting, and epigastric pain). Cumulative ''per protocol'' cure rate was 66.1% (CI 95%, 58.5-75.3%). There was no statistically significant differencebetween the two treatment groups: 58.9% (CI 95% 48.4-74.6%) versus 72.3% (CI 95%, 60.7-82.5%). Intention to treat does not substantially modify results. Few side effects were recorded. Cured patients showed a significant reduction in the activity of gastritis. Conclusion: azithromycin, combined with omeprazole and metronidazole, the cure rate of H. pylori was about 70%. The cure of H. pylori infection improves the activity of gastritis.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/09/20 alle ore 07:16:12